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Isolement et caractérisation d'une substance antifongique élaborée par Pseudomonas fluorescens 
FSJ-3, active contre des champignons pathogènes de l'homme 
La souche FSJ-3 de Pseudomonas fZuorescens douée d'une forte activité antifongique contre les champignons 
pathogènes de l'homme a été isolée à partir du sol (Fès, Maroc). La substance active, élaborée par cette souche, a 
été extraite du milieu de culture liquide, avec du n-butanol et purifiée par chromatographie sur gel de filtration 
et sur gel de silice. Le I-phénazinecarboxamide, obtenu sous forme de cristaux jaunes, a été analysé par RMN -IH 
et I3C et par spectrométrie de masse. Cette molécule inhibe la croissance de plusieurs bactéries, levures et 
champignons filamenteux, comme Candida albicans, Cryptococcus neoformans , Aspergillus fumigatus. Le 1-
phénazinecarboxamide provoque des altérations morphologiques sur les hyphes d' Arthroderma simii. À forte 
concentration (200 pg/ml), il n'est pas toxique pour les leucocytes de rat. 
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Isolation and characterization of an antifungal agent active against human pathogenic fungi, 
produced by Pseudomonas fluorescens FSJ-3 
An antifungal agent, produced by Pseudomonas fiuorescens strain FSJ-3 originating from Moroccan soil (Fès), was 
isolated and characterized. It was extracted from Sabouraud's glucose broth culture by n-butanol and purified by 
gel filtration and silica gel chromatography giving yellow crystals. Its structure was assigned to 1-
phenazinecarboxamide by analysing IH and 13 C-NMR and mass spectral data. It shOwed excellent activity 
against several species ofbacteria, yeasts and human pathogenic filamentous fungi , including Candida albicans, 
Cryptococcus neoformans, Aspergillus fumigatus and caused morphological modifications on Arthroderma 
simii hyphae. I-phenazinecarboxamide was non toxicwhen tested on rat leucocytes up to the highest concentration 
(200 pg/ml). 
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INTRODUCTION 
Several antimicrobial substances produced by 
Pseudomonas species have been found. The nature 
of these products was variable (Katayama 
et al., 1993 ; Kintaka et al. , 1981 ; Kintaka. et 
al., 1984; Shoji et al., 1990). Among them 
phenazine compounds (Gurusiddaiahet al. , 1986 ; 
Jones et al. ,1988 ; Kanner et al. , 1978) such 
as phenazine-1-carboxylic acid and 1-phenazine-
carboxamide. The activity of these substances 
against bacteria qnd phytopathogenic fungi has 
been reported (Gurusiddaiah et al.,1986). On the 
contrary, little is known about the activity ofthese 
agents against zoopathogenic fungi. 
This paper deals with the production, isolation and 
activity against yeast and human pathogenic fungi 
ofthe antifungal agent, produced byPseudomonas 
fluorescens strain FSJ-3 isolated from Moroccan 
soiL 
MATER~SANDMETHODS 
1. Production of the antifungal agent 
For production of antifungal compounds, the 
Pseudomonas fluorescens FSJ-3 strain was 
isolated from a soil sample collected in Fes city, 
(Morocco), and grown on Sabouraud's glucose broth 
(peptone: 5 g; glucose 20 g; caseine hydrolysate 5 g; 
distilled water; pH 5.8). The culture medium (2.5l) 
was placed in five erlenmeyer flasks, containing 
each 500 ml ofbroth and autoclaved at 120°C for 15 
min. After autoclaving the flasks were inoculated 
with 50 ml of two days old pre culture of P. 
fluorescens and incubated at 30°C on a shaker 
(Lab. Shaker Adolf Kuhner Ag Schweib) at 90 rpm 
for 10 to 12 days. 
2. Biological assays 
Antifungal activity ofthe crude supernatant and of 
the different fractions obtained after each 
purification step was determined by 
microtechniques (Mor et al. , 1993) : 10 ml 
Sabouraud's glucose agar (at 45°C) containing 1()1 
of yeasts or 105 fungal spores suspension were 
poured over a Petri dish (diam 90 mm) and allowed 
to harden at room temperature. Round (diam. 4 
mm) or square (4x4 mm) slices were cut, deposited 
on one ofthe eight circles of an immunofluorescent 
Microprint slide and submerged in 10 pl of crudeP. 
fluorescens FSJ-3 filtrate. The microculture was 
incubated at 30°C. The inhibition of cellular 
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multiplication, spore germination and hyphal 
elongation and the morphological alterations were 
observed in a light microscope. The minimal 
inhibitory concentration (MIC) of the purified 
antimicrobial substances against bacteria, yeasts 
and several filamentous fungi were determined by 
a microplate automatized technique (Drouhet et 
al., 1986) (Nunk F 96 microtiter plates, Roskild, 
Denmark). 
The antimicrobial assays were performed in 
sterilized 96 weIl plates in a final volume of 100 ml. 
The Sabouraud's glucose liquid medium (100 ml) 
containing the antifungal agent in seriaI two fold 
dilution, 100 pl 0.4 % formol/water as negative 
control or without added antifungal agent as 
positive control was distributed with a multipipet. 
10 pl ofbacterial suspension (lOS cells/ml) , yeasts 
(105/ml ) or spores (106/ml) in the appropriate 
culture medium (LB medium for bacteria, 
Sabouraud's glucose broth for yeast and fungi) 
were added to each weIl. Growth inhibition was 
determined by measuringthe optical density at 492 
nm with a Titertek Multiskan Mcc after 48 hours 
or 72 hours of incubation at 30°C for yeasts and 
fungi or 37°C for bacteria. 
The bioautography technique was used for 
composition analysis of crude extract and 
antifungal agent localisation. Aliquotes of each 
fraction (1 to 5 ml) were loaded on silica gel thin 
layer chromatography (TLC). The chromatograms 
were developed in appropriate solvent. These 
plates were dryed and antifungal substances were 
detected by depositing the TLC plates on 
Sabouraud's glucose agar Petri dishes including 
the indicator strain (Arthroderma simii 105 spores/ 
ml). After pre diffusion at room temperature, 
inoculated plates were incubated at 30°C for 48 
hours. The inhibitory fraction was detected by 
showing clear zone arround corresponding spot. Hs 
Rf was then measured. 
The cytotoxicity of 1-phenazinecarboxamide was 
assayed by monitoring the permeability of rat 
polymorphonuclear leucocytes (1(J:i Cens/ml) to 
trypan blue (0,1 g/l). After 10 minutes of incubation 
in the presence of antifungal substance, dead cens 
(coloured) were counted. The substance was 
considered as nontoxic when cell viability is more 
than 95%. 
3. Isolation of the antifungal agent 
P. fluorescens FSJ-3 culture broth was centrifuged 
at 3500 rpm. The supernatant was extracted twice 
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with n-butanol (11). After separation of the aqueous 
and organic phases, the inactive aqueous phase 
was discarded, and the active butanol phases were 
combined and the solvent removed under reduced 
pressure. The residue (7.25 g) was submitted to gel 
chromatography on Sephadex LH 20 (67 x 2 cm) 
with methanol as eluent. The fractions were 
collected and submitted to antifungal tests. The 
active fractions were pooled and chromatographed 
on a silica gel column (50 x 2 cm), eluted with 
methylene chloride (500 m1), and with methylene 
chloride/methanol (95:5) and (90:10). Crude 1-
phenazinecarboxamide (PZC) (50 mg) was eluted 
with methylene chloride/methanol (90:10). It was 
further purified by silica gel chromatography 
(20 x 1 cm) and eluted withn-hexane/EtOAc (1:1). 
4. General methods 
Melting point was uncorrected. Mass spectrum was 
taken under electron impact (70 eV) using direct 
inlet sample introduction on a Kratos MS 80 
spectrometer. 1H (300.13 MHz) and 
13C (75.47 MHz) NMR spectra were performed for 
a 25 mM solution in CDC13 on a Bruker AM 300 
spectrometer equipped with an Aspect 3000 
computer. 1H and 13C chemical shifts were 
referenced to tetramethylsilane (TMS). 
5. Thin layer chromatography 
The purification steps and the homogeneity of the 
isolated compounds were monitored by silica gel 
thin layer chromatography (TLC) with the 
following systems: silica gel G 60 F 254 (Merck 
5554); n-butanol, acetic acid, water: 6/2/2 (BA W) or 
methylene chloridelMeOH: 9/1 (MCM). The plates 
were visualized either by UV (235 and 265 nm) or 
bysprayingwith anisaldehyde reagent (acetic acid, 
sulfuric acid and p-anisaldehyde : 25/1/1) and 
heating (120°C). The Rf of 1-phenazine-
carboxamide was in BAW: 0.86 and in MCM : 0.91. 
6. I-Phenazinecarboxamide properties 
Yellow crystals (m.p: 248°C) soluble in chloroform, 
dimethylsulfoxide, insoluble in methanol and 
water. EIMS: mlz (rel. int) : [Ml+ 223 (67~ 205 
(40);[ M-NH21 + 207 (23);[ M-CONH21 + 18Ô~tIOO) 
[M-CONH21 + 179 (40); 152 (123); 129 (5); 112 (3); 
102 (13); 90 (12); 76 (19). 
1H NMR (CDCI3, 300.13 MHz ), (5 (ppm), J (Hz) : 
10.68 (lH, bs, CONH2 anti ); 8.99 (lH, dd, 7.1, 1.3, 
H-2); 8.40 (lH, dd, 8.7,1.3, H-4); 8.27-8.18 (2H, H-
6, H-9); 7.94 (lH, dd, 8.7, 7.1, H-3); 7.90-7.87 (2H, 
H-7, H-8); 6.41 (lH, bs, CONHsyn). 
13C NMR (CDC13, 75.47 MHz), (5 (ppm) : 166.6 
(C=O) , 143.4 (C4 a), 143.1 (C5 a #), 141.5( C9 a #), 
140.8 (CIO a), 135.9 (C2), 134.3 (C4), 131.7 (C8*)' 
131.l(C7'") 129.9 (C3),129.7(C9§ ), 129.1 (C6 §), 
128.9 (Cl); assignement with, #, *, and § may be 
reversed. 
RESULTS AND DISCUSSION 
• Extraction and purification of 
I-phenazinecarboxamide 
After incubation at 30°C for 12 days , the culture of 
P. fluorescens FSJ-3 was centrifuged and filtered, 
and the culture broth was extracted two times with 
n-butanol. The organic extract exhibited 
antifungal activity, whereas no such activity was 
detected in the aqueous phase. The organic extract 
was thus fractionated as described in figure 1. We 
obtairied 35 mg of pure 1-phenazinecarboxamide. 
Through the purification steps, aliquotes from each 
fraction were tested for antifungal activity. 
Fractions containing antifungal agent showed 
strong growth inhibition against Cryptococcus 
neoformans and Arthroderma simii as suggested 
by their respective MIC's. 
Broth culture t Extraction with n-BuOH 
Crude extract t ~;xclusion ~hromatograghy (LH20, MeOHl 
Active fraction 
1 Adso~~tion chromatograghy Si02 
'f (CH2 C12 / Me OH) 
Crude 1-Phenazinecarboxamide 
.1. Adsorption chromatography Si02 y (n-Hexane / AcOAt) 
1-Phenazinecarboxamide 
Figure 1. Isolation and purification of 
I-phenazine-carboxamide from 
Pseudomonas fiuorescens FSJ-3 
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• Spectroscopie characterization of 1-
phenazinecarboxamide 
Several spectroscopic studies (IR, IH and 
13C NMR) of antibacterial phenazine compounds 
have been reported in the literature (Breitmair & 
Hollestein , 1976 ; Gurusiddaiah et al., 1986 ; 
Romer, 1982 &1983 ; Stammer & Taurins,1963), 
but spectroscopic data on 1-phenazinecarboxamide 
(PZC) are less documented. 
El mass spectrum ofl-PZC exhibited the molecular 
ion at rn/z 223 and a fragmentation at 207 
characterising the loss of the amino group. The 
peak at m / z 179 indicated the loss of carboxamide 
group; it was accompanied by the base peak at 
m / z 180 which indicated a rearrangement due to 
the capture ofhydrogen to complete the phenazine 
ring. This had been previously observed by Kanner 
et al. (1978). 
The 1H NMR spectrum (CDCIs) exhibited two 
broad singlets at 10.68 and 6.41 ppm 
representative of the anti and sym protons of the 
carboxamide group, respectively. The 
monosubstituted phenazine ring showed the 
characteristic pattern: three resonances appeared 
as doublets of doublets at d 8.98, 8.40 and 7.94 
corresponding to H2, H4 and H3 respectively, and 
consistent with the carboxamide substituent effect 
in benzene. 
The chemical shift of H2 was unambiguously 
assigned from observation of it 3J C-H coupling to 
the carboxamide CO group in the HMBC spectrum. 
The resulting assignement of H2 and H4 are 
reversed, as compared to that found in the 
literature (Gurusiddaiah et al., 1986 ; Romer, 
1982). 
The remaining protons belonging to the 
unsubstituted aromatic ring exhibited the ABCD 
pattern of the phenazine rings, wich H6 and H9 
between 8.27 - 8.18 ppm and H7, H8 between 7.90 
- 7.87 ppm, in agreement with previous studies on 
1-phenazine carbomethoxy (Gurusiddaiah et 
al., 1986 ; Romer, 1982). Data are given III 
materials and methods. 
1-phenazinecarboxamide was the subject of 
different 13C NMR studies (Breitmair & Hollestein 
, 1976 ; Romer, 1983). The assignements resulting 
from the two studies were different. Therefore we 
assigned the 13C NMR spectrum of 1-
phenazinecarboxamide from the HMBC spectrum. 
Nevertheless, due to overlapping of some 1H 
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resonances, some of the assignements may be 
reversed (see materials and methods). 
A controversy occured in the literature concerning 
the structure elucidation of the closely related 1-
phenazinecarboxylic acid. A dimeric structure had 
been proposed by Gurusiddaiah et al. (1986), 
whereas Brisbane et al. (1987) provided evidence 
for the monomeric structure, which was definitely 
accepted from unequivocal evidence of the crystal 
structure (Romer, 1983). 
The spectroscopic data presented here are in favour 
of the monomeric structure of the isolated 
antifungal agent (Figure 2). 
Figure 2. Structure of I-phenazinecarboxamide 
isolated from P. fluorescens FSJ-3 
• Biological properties of I-phenazine-
carboxamide (l-PZC) 
The spectrum of antimicrobial activity of I-PZC is 
presented (Table 1) in terms of minimal inhibitory 
concentrations (MIC) giving; 100 % inhibition ofthe 
microorganisms tested, including Gram-positive 
and Gram-negative bacteria, yeasts and 
filamentous fungi. 
However, various microorganisms exhibited 
different degrees of sensitivity, as indicated by the 
MICs in the range 0.3-100 ].lg/ml. The antibiotic 
showed strong activity against bacteria (such as 
Entercoccus faecalis) and several fungi, 
particularly dermatophytes. It exhibited also 
moderate activity against other bacteria and 
yeasts. The I-PZC inhibited spore germination and 
growth inhibition of A. simii and caused 
morphological modifications in hyphea (Figure 3). 
In growth inhibition assays performed on 
mycelium of A. simii, no visible hyphae elongation 
could be seen in treated sample, whereas untreated 
sample developed long hyphae. Observation of 
mycelium in light microscope indicated clearly that 
the hyphae of A. simii were altered. The cytoplasm 
was contracted and empty spaces appeared in 
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fungal celIs and sometimes protoplasm ejection 
were noted. Different data (non reported here) 
suggets that the FSJ-3 strain of P. fluorescens 
produce minor antibiotics that also exhibit 
antifungal activity. 
These products could probably be minor 
phenazines types since Pseudomonas sp was 
reported to produce more than one phenazine 
(Chang & Blackwood, 1969 ; Kanneret al., 1978, 
Toohey, 1965). 
I-phenazinecarboxamide produced by 
Pseudomonas fluorescens FSJ-3 did not induce 
obvious damage to rat leucocytes in vitro and did 
not affect the permeability of leucocytes up to the 
highest concentration assayed (200 ].1g/ml). 
Gurusiddaiah et al. (1986) reported that a dimer 
phenazinecarboxylic acid was no toxic to mice 
receiving up to 464 mg/kg of the antibiotic by oral 
route. 
Table.1. Spectrum of antimicrobial activity of 
1-phenazinecarboxamide reported in 
terms of minimal inhibitory 
concentration (MIe) 
Test organisms Strain MIe (J.1g/ml) 
Pseudomonas aeruginosa ** 100 
Enterococcus faecalis IP 103214 0,39 
Staphylococcus aureus IP 76-25 50 
Cryptococcus neoformans IP 960 50 
Candida albicans IP 88465 100 
Trichophyton rubrum IP 2043 12,5 
Trichophyton mentagrop IP 1468 12,5 
Arthroderma simii IP 90265 25 
Arthroderma benhamiae IP 1064 12,5 
Microsporum canis IP 1194 3,12 
Aspergillus niger IP 21853 12,5 
Aspergillus fumigatus IP 1025 100 
IP: Institut Pasteur of Paris (France) 
** Strain isolated from onycomycosis patients 
Figure 3. Hyphal elongation inhibition and morphological effects of I-phenazinecarboxamide on A. simii 
a: control: elongation hyphae b: inibition ofhyphae elongation 
c: cytoplasmic condensation d: protoplasm ejection 
Bar equals: 50 mm. 
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